Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,033.41 -38.22 (-0.75%) Dow
37,998.32 -462.60 (-1.20%) Nasdaq
15,545.04 -167.71 (-1.07%) Bitcoin USD
64,589.88 -218.18 (-0.34%) CMC Crypto 200
1,391.74 +9.17 (+0.66%)
Shineco, Inc. (SISI)
| Previous close | 0.7601 |
| Open | 0.7890 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.7651 - 0.8000 |
| 52-week range | 0.6110 - 7.5000 |
| Volume | |
| Avg. volume | 432,981 |
| Market cap | 4.907M |
| Beta (5Y monthly) | -0.16 |
| PE ratio (TTM) | ∞ |
| EPS (TTM) | 0.0000 |
| Earnings date | 09 May 2024 - 10 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireShineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING, March 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that on March 11, 2024, the Company received formal notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company has evidenced compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule5550(a)(2). The notice indicated that as a re
- GlobeNewswire
Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that the Company’s Board of Directors has approved a reverse stock split of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-10. The Company is effecting the reverse split to regain compliance with the $1.00 minimum bid price required for
- GlobeNewswire
Shineco Announces the Appointment of Two New Executive Officers
BEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its Board of Directors has appointed Ms. Xiaohui Wang and Mr. Chi Keung Yan as executive officers of the Company in key leadership roles. Effective November 13, 2023, Shineco’s Board of Directors appointed Ms. Xiaohui Wang as Executive President of the Company. From March 2000 to November 2013, Ms. Wang
